How Long Should You Be on Wegovy for Weight Loss?

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists like semaglutide have transformed weight loss treatment, but patients often wonder how long they should remain on therapy. Clinical trials show that sustained semaglutide use over 12 to 24 months produces the greatest weight loss and metabolic improvements, with discontinuation often leading to weight regain within months.

Typical Duration of Semaglutide Treatment for Weight Loss

Most patients starting semaglutide can expect an initial treatment window of 12 to 24 months to achieve their target weight. During the first 4 to 8 weeks, your body adjusts to the medication while appetite suppression begins. The most significant weight loss typically occurs between months 3 and 9, when the full appetite-reducing and metabolic effects become established.

The exact timeline depends on your starting weight, metabolic rate, lifestyle changes, and individual response to the medication. Some patients reach their goals in 6 months, while others benefit from extended therapy. PlexusDx providers help track your progress monthly and adjust treatment plans based on your real-world results, ensuring you stay on track without unnecessary delays.

Why Long-Term Maintenance Therapy Often Works Best

Research from clinical trials demonstrates that patients who discontinue semaglutide after achieving weight loss often regain 50% or more of their lost weight within one year. This occurs because the medication addresses appetite regulation and metabolic drive—processes that reactivate once treatment stops. For this reason, many healthcare providers now recommend maintenance therapy at a stable dose to prevent rebound weight gain.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

When to Adjust Your Semaglutide Duration and Dosing

Your dose may need to go up—your price won't. PlexusDx pricing remains flat at $189 per month regardless of dose adjustments, allowing your provider to optimize your therapy without cost increases. If you plateau in weight loss after 8 to 12 weeks at your current dose, an increase often restarts progress. Conversely, if you experience bothersome side effects, dose reduction or a temporary pause can help you tolerate the medication better.

Reassessing your treatment plan every 4 to 8 weeks ensures you're on the right path. Some patients benefit from cycling between active treatment and maintenance phases, while others do best on consistent, uninterrupted therapy. Your PlexusDx provider reviews your monthly progress, hunger levels, energy, and any side effects to tailor the duration and intensity of your semaglutide protocol to your unique needs.

Compounded Semaglutide vs. Brand-Name Wegovy: What's the Difference?

PlexusDx compounded semaglutide injection comes from licensed 503A compounding pharmacies and offers the same active ingredient as brand-name Wegovy, but at a lower cost and without membership fees or insurance requirements. Both require the same duration and commitment—typically 6 to 24 months of active treatment followed by long-term maintenance. The key difference is accessibility and affordability: PlexusDx semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan and is HSA/FSA eligible, making extended therapy more sustainable for most patients.

Whether you choose compounded or brand-name semaglutide, the clinical timeline remains the same: expect results over months, not weeks. PlexusDx also offers oral semaglutide for patients who prefer injections-free therapy, at $289/mo month-to-month, or from $249/mo on the 6-month plan. Regardless of format, your provider will guide you on how long to stay on therapy based on your response, side effect tolerance, and long-term weight maintenance goals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I stop semaglutide after reaching my weight loss goal?

While you can stop, clinical evidence shows most patients regain significant weight within 12 months after discontinuation. Many providers now recommend long-term maintenance therapy at a stable dose to prevent rebound weight gain. Your PlexusDx provider can discuss whether maintenance or cycling approaches fit your health goals and lifestyle.

What does research say about semaglutide duration?

The STEP trials showed that patients on semaglutide for 56 weeks lost an average of 12–18% of body weight, with continued benefits at week 68. When patients stopped the medication, they regained weight rapidly. Extended therapy (12–24 months or longer) maximizes results and weight stability.

How much does semaglutide cost per month at PlexusDx?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no membership fees, no insurance required, and HSA/FSA eligibility. Your dose may need to go up—your price won't, ensuring you can adjust treatment without cost surprises.

Are there side effects if I stay on semaglutide long-term?

Most side effects (nausea, fatigue, constipation) decrease after 4–8 weeks as your body adapts. Long-term use is generally well-tolerated, though some patients experience mild ongoing gastrointestinal effects. Your PlexusDx provider monitors you monthly to manage any concerns and adjust your dose if needed.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.